Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression-Reference-Cited by-同舟云学术

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression

Published:2010-02 Issue:2 Volume:59 Page:285-292
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Zhang Hao,Wei Jing,Xue Rong,Wu Jin-Dan,Zhao Wei,Wang Zi-Zheng,Wang Shu-Kui,Zhou Zheng-Xian,Song Dan-Qing,Wang Yue-Ming,Pan Huai-Ning,Kong Wei-Jia,Jiang Jian-Dong

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference41 articles.

1. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes;Saltiel;Cell,2001

2. Clinical review 125: the insulin receptor and its cellular targets;Kido;J Clin Endocrinol Metab,2001

3. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction;Michael;Mol Cell,2000

4. Pathogenesis of non–insulin-dependent diabetes mellitus;Yki-Jarvinen;Lancet,1994

5. Insulin resistance versus insulin deficiency in non–insulin-dependent diabetes mellitus: problems and prospects;Ferrannini;Endocr Rev,1998

Cited by 358 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant Extracts for Type 2 Diabetes: Mechanisms, Clinical Implications and Future Directions—A Systematic Review;Journal of Biobased Materials and Bioenergy;2024-10-01

2. Tetrahydroberberrubine exhibits preventive effect on obesity by activating PGC1α-mediated thermogenesis in white and brown adipose tissue;Biochemical Pharmacology;2024-08

3. Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments;Cancer Letters;2024-08

4. Study of the antidiabetic mechanism of berberine compound on FOXO1 transcription factor through molecular docking and molecular dynamics simulations;Journal of Molecular Modeling;2024-07-09

5. Berberine attenuates 5-fluorouracil-induced intestinal mucosal injury by modulating the gut microbiota without compromising its anti-tumor efficacy;Heliyon;2024-07